Skip to main navigation

Medical Device Coatings
Interventional Products
In Vitro Diagnostics
Investors
Our Company
- About Surmodics
- Ireland Facility
Careers
Contact Us

News Releases

News Releases

2025
2024
2023
Archive
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004

November 17, 2025

Surmodics Announces FTC Does Not Intend to Appeal Denial of Injunction, Order Preventing Closing Set to Expire Today

November 10, 2025

Surmodics Announces U.S. District Court Denies Request for Preliminary Injunction to Block Proposed Acquisition by GTCR

November 4, 2025

Surmodics Announces Outcomes from 160 Patients in PROWL Registry Evaluating Pounce™ Thrombectomy Platform in Treatment of Real-World Limb Ischemia Presentations

November 3, 2025

Surmodics Announces PROWL Registry 160-Patient Data to be Presented in Industry-Sponsored Session at VIVA Conference on November 3

October 29, 2025

Surmodics Announces Results from Sex-Specific Analysis of the PROWL Registry Study of Real-World Limb Ischemia Patients Treated with the Pounce™ Thrombectomy Platform

October 27, 2025

Surmodics Announces PROWL Registry Sex-Specific Data to be Presented at TCT Conference on October 28

August 8, 2025

Surmodics Reports Third Quarter of Fiscal Year 2025 Financial Results; Updates Fiscal Year 2025 Financial Guidance

August 6, 2025

Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8

April 30, 2025

Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial Guidance

April 28, 2025

Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30

April 22, 2025

Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon

April 3, 2025

Surmodics Announces Commercial Release of Pounce™ XL Thrombectomy System, Enabling Rapid Non-Surgical Clot Removal in Iliac and Femoral Arteries

March 6, 2025

Surmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated with GTCR

February 3, 2025

Surmodics Announces Successful Early Clinical Use of Pounce™ XL Thrombectomy System, Suitable for Non-Surgical Removal of Thrombi and Emboli from Iliac and Femoral Arteries

January 30, 2025

Surmodics Reports First Quarter of Fiscal Year 2025 Financial Results

Shareholder Tools

Corporate

9924 West 74th Street
Eden Prairie, MN 55344
USA
Toll Free: 1-866-787-6639
Phone: 952-500-7000
Fax: 952-500-7001

Golden Triangle

7905 Golden Triangle Drive
Suite 190
Eden Prairie, MN 55344
USA
Toll Free: 1-888-626-8501
Phone: 952-500-7400
Fax: 952-500-7001

Ireland

IDA Business Park
Ballinasloe, Co. Galway
Ireland
Phone +353 90 9646300
Fax +353 90 9646309

Products

Interventional Products
Performance Coatings
Drug-Coated Balloons
In Vitro Diagnostics

Our Company

About Surmodics
Contact Us
Investors
Careers

Documents

eIFUs
Privacy Policy
Term of Use

© 2026 Surmodics, Inc. All Rights Reserved.